Hey, "smart", I concur with your message. Latest Posts. Created with Sketch. 19/09/23. 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. If only we had the viraleze. 56. We love cruising, but this multi billion dollar industry has effectively been shut down. ASX - Day TradingDoes Spl deserve to be seven times less in mkt cap to another biotech that has one phase 2 product spl potentially 3 and commercialisation deal with astra zeneca and collaboration deals with Merck and Genentech. I think SPL are very worried on what a potential class action could implicate. 45K. ASX - Day TradingCurrent SPL CEO setting a pretty high bar here, especially in light of the less than sparkling track record. Overview. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Share In the last year we have seen the resignation of the Head of Research, David Owen and now the Chief Financial Officer, Nigel Baade. Latest Posts. Unusual to make that announcement?. 70% 14. Join the HotCopper ASX Stock discussion forum for STARPHARMA HOLDINGS LIMITED. bc. Charts. 47pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on NOVONIX LIMITED. Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. 0 Created with. Share Step 1. 54pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on BETMAKERS TECHNOLOGY GROUP LTD. To be fair the ASX has made tries on 3 recent contracts to squeeze information from SPL when didn’t want to disclose how immaterial the contracts is. . We, as investors in this company deserve to knowmore. Market Cap $57. 0¢. Starpharma are 4+ years from their CRL for Vivagel and we really are none the wiser of what is going on apart from a snippet in the AGM presentation stating 'we. ASX - Day TradingI will just put it out there that I have been peeved off about our CEO Jackie Fairley and the performance of SPL for a while now. The matter has been adjourned to. Charts. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 0¢. . 0¢ Sentiment: Buy. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. Dr. $1. 5. SUBMISSION STEPS. Investors and the ASX now have their eye on SPL like they normally would have on dodgy mining penny stocks. Share Yes, this is pre-clinical data, HOWEVER, on this occasion this positive data (of adding Starpharma’s conjugate to IO drugs) directly supports commercial negotiations for the soon to be released top-line results for DEP-Irinotecan, in my opinion. ASX - General. SPL. bc. FDA, TGA, MHRA to pick fights and get knocked out and 2 blood noses. I sold out of my position in SPL at that time precisely because of this. ASX - By Stock. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. ASX - By Stock. Advertise on HotCopper. Advertise on HotCopper. Just to refresh people's memory I thought this summed by the exact situation with the TGA and Starpharm STARPHARMA’S COVID-KILLER NEEDS ACTION NOT. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Last updated 15. Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’: SPL are obliged to make announcements and unfortunately they have not included enough detail so shareholders are aware of timings and actual release in Indonesia nor real scale. SPL is not a penny dreadful (not yet anyway) and it is not a resources company and it has enough funds to last a few more years even if it never makes a cent. 63. New Zealand Dollar. Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. As Waldemar Januszczak said when looking at the portrait of Mr & Mrs Andrews by Gainsborough "THERE IS SOMETHING GOING ON here". ASX - General. Created with Sketch. . Latest Posts. It would be nice to have SPL make an announcement to the market to clear up the uncertainty around the many market sensitive announcements made that seem to have just faded into the background with no update as to whether they are progressing or if they have ceased. And somebody must be buying all the shares that are being sold. 0012. Working in a. All the case studies have already been touted by SPL in various ASX announcements and the only trial that is declared finished by Starpharma and scheduled for readouts is DEP Cabazitaxel and that isn't until in Q3 CY2023 ,. ZEUS RESOURCES LIMITED. . And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . SPL scientists will no doubt be working on this right now. . SPL have put a lot of time and energy into Docetaxel and Cabazitaxel over many years but it is Irinotecan that seems to be wining the race, probably benefiting from the accrued knowledge from the Doc and Cab trials. 00 and $5. 8%. . I can't guess where or what or when, perhaps there is an informed opinion out there in HC SPL land but we have a very tight market and some. Latest Posts | Join the HotCopper forum today for free, page-1. Created with Sketch. Forums. ASX - Day TradingLast day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sellThe deal, which has an initial duration of 12 months, has the same terms as the previous agreement. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. GLTAH but for me SPL is still a strong AVOID until a development of substance is announced. distraction achieved. Forums. Created with Sketch. Created with Sketch. Share It is VERY disappointing that a CEO, Chair and company secretary can still throw a Sky and Land logo onto a corporate presentation as an indication of a partnership even though after 6. 0¢ Sentiment: Hold Disclosure: Held Share Hi Folks Time to revisit the SPL Weekly chart. Some paralllels with SPL, although every product and data is different, but a least MSB are pretty clear with CRL - not pretty fro shareholders and going to take a lot of funding and dillution to achieve trial that could have been completesd in that same timeframe and IMO a lower risk. Market . ASX - By Stock. ASX - General. Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). 5¢. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. Click for more information. SPL has great optionality, potential and a healthy balance sheet to ride out the current storm. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is different SPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. Target our investor community. ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. Viraleze being 1% less efficacious against the more potent dangerous new strains is an awesome result and should be celebrated. 00%. The real story is SPL hasn't been 63 cents since 24/3/2020 that's not a 52-week low, that's a 114-week low! 2 years 3 months since its seen that price. Created with Sketch. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Time flies. 15667. I visited their offices in Melbourne near the Alfred a few times and thought they were on to some pretty neat tech. Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. ASX - Day TradingAnyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. The thread is titled so that it can be found and general enough so as to. Latest Posts. , page-2. ASX - By Stock. Market . 0. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). " Indeed. Surely, surely these great technical achievements will translate into commercial gains for the company and us long suffering SPL Shareholders. 0000. 03% or subsequently a decrease in shorts of. ASX - General. SPL. Created with Sketch. Hey, "smart", I concur with your message. podcasts, and hotcopper) Reading announcements from Starpharma and having to decipher what is actually being said And finally, lacking the ability to sell our products currently. The recent announcement about Viraleze nasal spray going into production in Jan 2021, trying to hit the Euro markets in q1-q2 2021, caused a stir in the SP. However, I think that maybe SPL is occasionally worth a swing trade gamble. This will make for sad reading. Disowned him really. ASX - By Stock. $0. Target our investor community with our. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer model (BT474). 0. We know that they haven't been marketed well but i think BigPharma have had an input. Don’t look to him for the truth lol. 367026. 11%. 5,006,219 was the total short sales as of 21/07/23 (1. Created with Sketch. 36. ASX - Short Term Trading. Name/company Polymer Drug, class/loading method Delivery system type/size Clinical stage/indication; CPC634. Latest Posts. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. . It totally unrealistic that Merck will enter the clinic in 4-5 months. Starpharma have so far been quite disappointing in the way it has commercialised products The Vivagel condom A dismal failure so far It had been approved. Latest Posts. SPL. $0. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. Latest Posts. ASX - By Stock. 32 , that is a daily rise of over 50% on the market capital at the time it hit that low. “If humans respond in a similar way, the benefits of treatment. Twelve month SPL daily chartSame old trend continues. ASX - By Stock. 48. 11%. 0¢ STARPHARMA HOLDINGS LIMITED - Corporate Spotlight . 0. Shouldn’t company have announced departure of key person when. m. Created with Sketch. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Dec 14 (Reuters) - Starpharma Holdings Ltd (SPL) : VIRALEZE NASAL SPRAY REGISTERED IN INDONESIA PROGRESSING DISCUSSIONS WITH POTENTIAL DISTRIBUTION. 9¢. See All Discussions. IMO they haven't . It’s incredibly important to keep us informed. * All the touted pending/expected deals with the Majors come to very little with the usual statement "in discussions"Created with Sketch. Created with Sketch. In SPL's case there is clearly another. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. 63. 06 Sentiment: Buy Disclosure: Held Created with Sketch. 138. The total and absolute shame of this is that not once in their quarter of a century of existence have these "discussions" amounted to a deal. 5230. ASX - By Stock. It must be great to ride the ASX executive remuneration gravy train like CEO Fairley has done for 18 years with Starpharma, and Chairman Rob Thomas has done for the majority of his long career. . AB you'd better start going out on Friday nights and liveing it up to get in practice for the celebrations when SPL hits the big time! SPL Price at posting: $1. . $0. Canadian Dollar. I'd think that SPL will be covering all the bases required for a crack at 505b2, but with the necessary data to pivot to a phase 3 trial if. 53pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. Since then. ASX - Day TradingCreated with Sketch. I am STILL inviting comment on SPL and their Zika proclamations, and how this is evidence of SPL’s long standing crumb throwing method. m. I constantly question why I continue to subject myself to the ongoing. Share I sometimes wonder if they actually work at Starpharma. 75. June 9 (Reuters) - Starpharma Holdings Ltd (SPL) : STARPHARMA CEO TO RETIRE IN 2024 FOLLOWING SIGNIFICANT TENURE AS COMPANY'S CHIEF EXECUTIVE OFFICER. Created with Sketch. 607432. Market . Once they think they can get AZD0466 to market they will pounce if our share price is less tan $2. 5¢. I think with SPL we are up to series 10 episode 100!!!! and I do laugh a lot mostly at posters naiviety On your part pretty poor form comparing such a classic comedy with such a tragic live comedy watched on the market everyday !!Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. ASX - By Stock. See All Discussions. NEW YORK TRANSN DEV CORP SPL FAC REV 4. 3. And somebody must be buying all the shares that are being sold. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . In SPL's case there is clearly another. Last updated 15. 00% 14. FORTESCUE METALS GROUP LTD. SPL Price at posting: 44. I should declare that I am. The reason I loaded up in the year post the last agm was because we we falsely told that vivagel would would be launched in Q1. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). He doesn't "hold" but 99% of his posts are on SPL, including a remarkable 350 in the last two months alone. ASX - By Stock. . Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. . Slow golf clap for Jackie Fairley. J K Fairley $1,272,084N J Baade. I remember seeing a post on SPL had 41000 views. Advertise on HotCopper. comImagine what SPL's newflow and updates would look like without Viraleze. Last updated 10. Friday 26/06/2020 looks like the slide deck is very similar if not identical to last Friday's audio presentation I will be recording audio just in case this audio presentation is differentSPL management team get bad marks for delays all the time but I don’t read anyone citing possible reasons. any other information the entity wishes to notify to ASX about the cessation?The Performance Rights issued under an employee incentive scheme lapsed during the course of the quarter ended 30June 2023 include 519,053 Rights held by KMP, Nigel Baade, and 310,760 Rights held by non-KMPs. Market . ROFL. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial. ASX - By Stock. Share Interesting and positive early pre-clinical results. The ASX is trying to crack down on many companies. ASX - Day Trading. Last edited by sarge17: 28/11/22. Created with Sketch. If they have poster data now it shoud be released to shareholders especially since they have used qualifying words such as good etc etc . Target our investor community with our suite of Hotcopper. S. are either confused or talking nonsense. ASX - Day TradingHi guys, I have held SPL shares for over 9 years and I will continue to hold. SPL polylycine dendrimers are proving to play a major role in the future of ADC’s. HotCopper is Australia's largest free and independent stock market trading forum for. Forex. All IMO this highlights the problems with agreements where there is seemingly no min order quantity and obligation to advertise and promote the product. Merck will fund the research, although Starpharma doesn’t expect the fees to be material, and. LEADING THE BATTERY METALS REVOLUTION. 1. StarPharma Holdings Ltd. 4¢. ASX - Day Trading. Share So I am guessing nothing came from the Merck meeting Jackie given they were promoted by name in the Shareholder Update on 3 June as a big meeting to be held on the USA holiday ASCO trip and they have been a 'partner' (and I use that term lightly with this mob) for 10 months longer than Genentech so Merck's research should be much further advanced IMO there’s money to be made trading SPL but I do not believe in holding, hoping, trusting and loving SPL at all. Last updated 15. . NSX - By Stock. Created with Sketch. SPL have hit road blocks with many of their products. Created with Sketch. Yes I think SPL does have a future but TIME is of the essence. . Created with Sketch. Created with Sketch. 0¢ Sentiment: Hold Disclosure: Held LikesSPL 7013 is already approved for use in the body (via a mucous membrane) and there would seem to be no issue as regards safety. Just sayin'. 129294. There have been so many market sensitive announcements made and then ZEROfollow up on these announcements. Forums. You would think that somewhere SPL woudl have commented that TGA is awaiting data from UK trial. 26. The 407730 is a sound level meter that measures from 40 to 130dB with an accuracy of 2dB. Created with Sketch. Both were very well paid and, if the "forward looking statements" are to be believed would have had the box seat in a company with a great future. yet if one considers that the amount of millions of shares via option they. IMO they haven't . Looking at the short term, SPL's SP is currently perched above a technical support line at 50 cents. OR no reponse at all. The main difference between shareholders and the board and their illustrious leader seems to be just in use of English language, small discrepancies like "well advanced" might me to you or I an agreement is pending, can be expected shortly, what it means to Jackie it would seem is she has undertaken a google search to see who might sell a product such as Viraleze in an particular country. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Forums. 0¢. Join the HotCopper ASX share market forum today for free. The lab that is. and the Government Medical Research Fund which provided $1mil to SPL to aid in developing Viraleze. Only 12 episodes made but so Iconic . . Stay informed on the day’s latest market trends and receive exclusive access to HotCopper’s trending analysis with inside stories from TMH to help you make sense of what’s happened and navigate what’s ahead. *talks with BIG multinational Company, should've already taken place with deals completed and signed soon after the trial. Market Cap $77. Share Many media conferences during the Pandemic we heard of Victorian initiatives for covid treatments or preventative by Dan Andrews or Brett Sutton - so VICTORIA has questions to answer. Just begin to imagine that all staff on board use Viraleze well before. Latest Posts. ca/pst. 3¢. 6. ASX - General. StarPharma Holdings Ltd. The digital display offers a 0. HotCopper has news, discussion, prices and market data on PROTEOMICS INTERNATIONAL LABORATORIES LTD. Share Given the current status of Starpharma, I am surprised any of these made it through from 2020 but it appears 121,082 did. SPL Price at posting: 91. 72. 22/9/2000 CSL $11. ASX - By Stock. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Advertise on HotCopper. Application for quotation of securities - SPL. Join the HotCopper ASX share market forum today for free. . 5¢. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Join the HotCopper ASX share market forum today for free. Click for more information. I was astounded to see that you Jackie were rewarded with a$200,000 bonus during this time. Can anybody load up the most recent Bell Potter Analysis on SPL? I am unable to source it thanks. This sort of action happens fairly often with SPL then followed by a pull back. . It was fairly obvious to the market that a crap raise was coming, and the SP might rise on this last chance in a while being out of the way before SPL is well capitalised. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial ReviewAbout this app. 49M. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Share It's confusing isn't it So what we have in pre-clinical trials Dep Docetaxel has been used in combination with Gemcitabine Dep Cabazitaxel has been used in combination with GemcitabineReading the TGA decision to fine Starpharma re Viraleze in 2021, and the requirement that SPL apply for approval of Viraleze as Medicine not Medical Device which has been the approval category in many other jurisdictions, I understand from questions I asked at the November 2022 AGM that SPL paid the fine and were concerned that there. Canadian Dollar. Hey, "smart", I concur with your message. ” This, sadly, is not true. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. ” ~@sarge17 Last edited by sarge17 : 24/02/23 SPL Price at posting: 54. It is lengthy but well worth the time. Check out the spin on this promo---One ASX company Set to Revolutionise the $112 BILLION Cancer-Drug MarketBy: Adam SurpliceIndustry experts expect that. So on the one hand you state SPL isn't a nasal spray company. Join the HotCopper ASX share market forum today for free. . CEO knows it is all going. Some links within this article worth a scan too. 28pm 13/11/2023 ? TMG (ASX) Chart. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Actually I worked for a research firm that supplied SPL with online medical literature and patent research back in the early 2000s. But the products were developed as proof of a saleable dendrimer product. . Eight (8) contributors to the HC SPL thread made price predictions (thank. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. . Eight (8) contributors to the HC SPL thread made price predictions (thank. 16,364,160. Join the HotCopper ASX share market forum today for free. Charts. The CEO chose to drop a throwaway line at the end of her presentation to potential investors as reported by Antibotter ie “ Starpharma are pursuing registration in China for Viraleze “ as one of if not the biggest market in the world one would think this is a price sensitive comment after all it was said as bait to potential investors. 6% (1. Join the HotCopper ASX share market forum today for free. However, the interim results from ongoing Phase One NCT04865419 (the most advanced trial) was a little underwhelming IMO. 5¢. Share Interesting and positive early pre-clinical results. Latest Posts. Created with Sketch. 8985. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago.